The Deputy Minister for Finance, Thomas Ampem Nyarko, has outlined the government’s plan to position Ghana as a leading pharmaceutical hub in West Africa, aiming to boost local employment and enhance the country’s economic resilience.
Nyarko shared the vision during a meeting with Dr. Sania Nishtar, the Chief Executive Officer of the Global Alliance for Vaccine Initiatives (GAVI), at the Ministry of Finance. The pharmaceutical hub is part of Ghana’s broader strategy to transition from GAVI’s direct support by 2030, with a focus on local production and self-sufficiency in health services.
“With the establishment of a pharmaceutical hub in Ghana, supported by GAVI, we aim to create employment opportunities and add value to our local resources. This is a critical step for the growth of the Ghanaian economy,” Nyarko said.
GAVI, a global health organization established in 2000, has been a vital partner in improving vaccine access and strengthening health systems across developing countries. Its support in Ghana has been instrumental in boosting immunization coverage, positioning the country as a leader in the sub-region.
GAVI’s role extends beyond vaccine provision, having played a significant part in improving local production capacities and healthcare infrastructure.
In Ghana, the proposed pharmaceutical hub aligns with efforts to reduce reliance on imported medical products, particularly vaccines. The move to establish a self-sustaining sector would not only strengthen healthcare resilience but also have broader economic implications, including job creation, industrial growth, and potential for foreign investment in the pharmaceutical industry.
